Metropolis Clinical Pathology will acquire and operate all laboratories and collection centers of Scientific Pathology in Agra and neighbouring towns through a slump sale transaction
VaxiFlu-4 is being marketed by Zydus Vaxxicare-a division of the group focussing on preventives
We will continue to expand our range of purified excipients, offering pharmaceutical companies a dependable partner
The company will offer end-to-end services and solutions for the sector with a specific focus on sustainability
Novel illumination system with key components molded in Radel® PPSU for durability and repeated sterilization
Reported revenue from operations up by 11% to Rs. 944 crores Reported PAT (after exceptional items) up by 18% to Rs. 131 crore
The company plans to fund this Capex through debt and internal accruals and expects the project to be completed by FY27
Expand the scope of the Production-Linked Incentive (PLI) scheme and increase its allocation to cover more pharmaceutical products and raw materials
The FDA determined that the data presented in a 2022 color additive petition show that this ingredient causes cancer in male laboratory rats exposed to high levels of FD&C Red No. 3 because of a hormonal mechanism that occurs in male rats
Biocon Biologics remains committed to global standards of quality and compliance
Subscribe To Our Newsletter & Stay Updated
